Impax Laboratories Inc (NASDAQ:IPXL)

46.21
Delayed Data
As of May 22
 +0.75 / +1.65%
Today’s Change
22.12
Today|||52-Week Range
52.10
+45.86%
Year-to-Date

Today’s Trading

Previous close45.46
Today’s open45.33
Day’s range45.11 - 46.56
Volume750,231
Average volume (3 months)723,583
Market cap$3.3B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+2.24%
Earnings growth (next 5 years)+26.41%
Revenue growth (last year)+16.53%
P/E ratio72.8
Price/Sales3.62
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.23+0.25%
WXWuXi PharmaTech (Cay...-0.13-0.30%
NBIXNeurocrine Bioscienc...+0.57+1.36%
RAREUltragenyx Pharmaceu...-1.76-2.07%
Data as of 4:02pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$0.10
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers